Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Recruiting · NCT06058234 · Registry updated 2023-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study | Cognition Disorders, Cognitive Dysfunction, cognitive disorder, psychiatric disorder | Recruiting | Not stated | 2023-09-28 | NCT06058234 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centers for Medicare and Medicaid Services/ Coverage and Analysis Group | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centers for Medicare and Medicaid Services | Baltimore | United States | 1 |